Watch Novo VP on Lilly’s Obesity Pill Approval - Bloomberg

Apr 1st, 2026

Novo VP Weighs In on Approval of Lilly’s Obesity Pill

Jamey Millar, executive vice president, US operations of Novo Nordisk, reacts to Eli Lilly’s once-daily weight-loss pill, called Foundayo, winning FDA approval on "Bloomberg The Close."

Top Video

Duration:34:34

Living With the Chinese ‘Tiger’

Duration:1:23

What to Expect From the Second Round of US-China Talks

Duration:1:57

Trump Says Boeing Wins 200 Jet Plane Order From China

Duration:1:00

Trump, Xi Raise a Toast at End of Day One

Duration:1:56

Xi Presses Trump on Taiwan

Duration:0:33

Trump Invites China’s Xi to White House in September

Duration:10:33

Trump Making China Great Again?

Duration:1:45

Xi Greets Trump With Lavish Ceremony

The China Show

Available on:

Listen onApple TV Listen onRoku Listen onSamsung TV Listen onFire TV Listen onAndroid TV Listen onRakuten TV Listen onHaystack News

Watch BTV in your area: